Physician profile
Brian Edward Lally
NPI 1114102407
$29,362.89
in general payments reported to CMS, 2019-2025
18 companies · $27K in 2025
The $27K reported for 2025 was more than what 98% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $34.37 · 2022: $280 · 2023: $196 · 2024: $1,240 · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Food and Beverage: $1,576 · Travel and Lodging: $1,369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,935.00 |
| Food and Beverage | $1,575.98 |
| Travel and Lodging | $1,369.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $27,787.28 | 2024-2025 | Imfinzi, Tagrisso |
| Novocure INC. | $361.04 | 2023-2024 | Optune, Optune Lua (Novottf-200t), Optune Lua (Novottf-200t) |
| Boston Scientific Corporation | $172.66 | 2024 | Spaceoar Vue System - 10ml |
| Icotec Medical INC. | $164.37 | 2024 | Vader Pedicle System |
| Ge Healthcare | $125.50 | 2025 | |
| Blue Earth Diagnostics | $125.00 | 2023 | |
| Siemens Medical Solutions USA, INC. | $123.51 | 2024-2025 | Truebeam, Aria Radiation Therapy Management Software |
| Seagen INC. | $111.78 | 2019-2022 | |
| Gt Medical Technologies, INC | $69.66 | 2022 | |
| Sirtex Medical INC | $62.22 | 2022 | |
| Merck Sharp & Dohme LLC | $52.68 | 2019-2025 | Keytruda, Lynparza |
| Karl Storz Endoscopy-America | $48.16 | 2022 | |
| Incyte Corporation | $38.01 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.30 | 2019 | |
| Tesaro, INC. | $36.92 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Palette Life Sciences, INC. | $18.46 | 2022 | |
| Karyopharm Therapeutics INC. | $16.56 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $11.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Lally listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.